Unrelated donor transplantation for acute myelogenous leukemia in first remission - sprookjes - yvandenbroek - TriplyDB

Unrelated donor transplantation for acute myelogenous leukemia in first remission

Unrelated donor transplantation for acute myelogenous leukemia in first remission

http://www.wikidata.org/entity/Q33841417

about

Progress in acute myeloid leukemia Anti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumors Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia.Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.

P2860

Q27024006-A911B230-1129-4C6F-8B8F-39AC4F063782 Q35921888-B5AC0357-FD25-45ED-972B-5D6B27DED75D Q37942816-04D1A88C-2774-40F1-8612-20C2A3E0531D Q38207595-9F93513E-BD50-42EB-852E-D54743B5B7B7

P2860

Unrelated donor transplantation for acute myelogenous leukemia in first remission

http://www.wikidata.org/entity/Q33841417

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Unrelated donor transplantation for acute myelogenous leukemia in first remission

@ast

Unrelated donor transplantation for acute myelogenous leukemia in first remission

@en

type

label

Unrelated donor transplantation for acute myelogenous leukemia in first remission

@ast

Unrelated donor transplantation for acute myelogenous leukemia in first remission

@en

prefLabel

Unrelated donor transplantation for acute myelogenous leukemia in first remission

@ast

Unrelated donor transplantation for acute myelogenous leukemia in first remission

@en

P1433

Q33841417-7838FDC6-B311-4F80-9F52-106511BD78AB

P1476

Q33841417-475C02C0-7031-43EF-A604-EC3CF830427C

P2093

Q33841417-48800358-630A-4AE2-BB43-F92906094426

Q33841417-50246385-5576-4CD0-BC08-37355A364475

Q33841417-5D102D62-5F43-46C5-974C-415969BCCB2C

Q33841417-6C8C701A-5274-4EBB-96A5-C81578C5231C

Q33841417-A94870C7-EB7B-483B-B0B3-87A3338C3514

Q33841417-B158896B-5F89-4F50-9CFB-982A062043B9

Q33841417-B54AA64A-B00D-4731-8349-F08959DE0393

Q33841417-C0F808FA-A723-46E9-816A-325861A4B33C

Q33841417-C75525B6-6770-4935-807F-EC38C9BA8FF8

Q33841417-D009B175-BE5E-4A71-82B7-432FA200CF28

P2860

Q33841417-05A9AB19-A966-41B1-9EDB-47BD724E89FF

Q33841417-0615C9C6-ECDB-47DE-B253-826F7EF9F7D5

Q33841417-105991A7-01EA-45C8-B84D-244892802EC6

Q33841417-12FD3E45-7C5B-4FC8-A886-6D5D468B392D

Q33841417-24C3EFE5-2FA7-43FE-BA56-835918C30DD1

Q33841417-278A097F-E386-4BBF-AFEF-AB2890B81AEF

Q33841417-28BEB443-2564-47E0-9489-A35BFE1EA2CB

Q33841417-356B0B67-2698-4D84-80CE-7E5BCF362DD0

Q33841417-3FF9F5B4-4678-4794-A685-B0C485265B81

Q33841417-5D6E1ADB-44C2-491C-AD6F-8399619483BE

P304

Q33841417-7A9DB715-2954-4D8F-9F05-FEA25CF2269A

P31

Q33841417-8D037A1B-5DA1-45F1-9D6F-3B03DB7C35A7

P356

Q33841417-F34D1ACF-1232-4AF7-84AE-F02222B85E32

P433

Q33841417-F39BD353-EE93-4966-BF62-75F5C9A72B27

P478

Q33841417-D6B3094D-3262-45BB-8B0D-FF253D2EF8FA

P50

Q33841417-1FC931A4-2F4C-4804-995E-5312D2F02FDC

P577

Q33841417-9AC81A62-FB5D-4AB5-B390-C098E8DECA06

P698

Q33841417-97660CD6-67AD-4C6D-B908-FD5FFB1967F0

P932

Q33841417-601FA071-AEBC-4592-9006-A4D54B23D4DF

P356

J.BBMT.2010.11.012

P1433

Biology of Blood and Marrow Transplantation

P1476

Unrelated donor transplantation for acute myelogenous leukemia in first remission

@en

P2093

Alexandre Chiattone

http://www.w3.org/2001/XMLSchema#string

Borje S Andersson

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Leandro de Padua Silva

http://www.w3.org/2001/XMLSchema#string

Manish Sharma

http://www.w3.org/2001/XMLSchema#string

Marcelo Fernandez-Vina

http://www.w3.org/2001/XMLSchema#string

Marcos de Lima

http://www.w3.org/2001/XMLSchema#string

Morgani Rodrigues

http://www.w3.org/2001/XMLSchema#string

Paolo Anderlini

http://www.w3.org/2001/XMLSchema#string

Qaiser Bashir

http://www.w3.org/2001/XMLSchema#string

P2860

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia

Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.

Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Busulfan in hematopoietic stem cell transplantation

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.

P304

1067-1071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2010.11.012

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21087679

http://www.w3.org/2001/XMLSchema#string

P932

4080632

http://www.w3.org/2001/XMLSchema#string